Table of Contents Author Guidelines Submit a Manuscript
Advances in Condensed Matter Physics
Volume 2015, Article ID 870602, 10 pages
http://dx.doi.org/10.1155/2015/870602
Research Article

Effect of Lidocaine and Epinephrine on Human Erythrocyte Shape and Vesiculability of Blood Cells

1Department of Orthopaedic Surgery, Ljubljana University Medical Centre, Zaloška 9, SI-1000 Ljubljana, Slovenia
2Laboratory of Clinical Biophysics, Faculty of Health Sciences, University of Ljubljana, Zdravstvena 5, SI-1000 Ljubljana, Slovenia
3US Naval Research Laboratory, 4555 Overlook Avenue SW, Washington, DC 20375, USA

Received 29 October 2014; Revised 27 December 2014; Accepted 12 January 2015

Academic Editor: Leonid Pryadko

Copyright © 2015 Tanja Slokar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Richter, R. Bérat, and A. R. Brisson, “Formation of solid-supported lipid bilayers: an integrated view,” Langmuir, vol. 22, no. 8, pp. 3497–3505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Tetta, E. Ghigo, L. Silengo, M. C. Deregibus, and G. Camussi, “Extracellular vesicles as an emerging mechanism of cell-to-cell communication,” Endocrine, vol. 44, no. 1, pp. 11–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Rak, “Extracellular vesicles—biomarkers and effectors of the cellular interactome in cancer,” Frontiers in Pharmacology, vol. 4, article 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Schara, V. Janša, V. Šuštar et al., “Mechanisms for the formation of membranous nanostructures in cell-to-cell communication,” Cellular and Molecular Biology Letters, vol. 14, no. 4, pp. 636–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Müller, “Microvesicles/exosomes as potential novel biomarkers of metabolic diseases,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 5, pp. 247–282, 2012. View at Google Scholar · View at Scopus
  6. A. Mrvar-Brečko, V. Šuštar, V. Janša et al., “Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope,” Blood Cells, Molecules, and Diseases, vol. 44, no. 4, pp. 307–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. El Andaloussi, I. Mäger, X. O. Breakefield, and M. J. A. Wood, “Extracellular vesicles: biology and emerging therapeutic opportunities,” Nature Reviews Drug Discovery, vol. 12, no. 5, pp. 347–357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Lee, S. El Andaloussi, and M. J. A. Wood, “Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy,” Human Molecular Genetics, vol. 21, no. 1, pp. R125–R134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Danielson and S. Das, “Extracellular vesicles in heart disease: excitement for the future,” Exosomes & Microvesicles, vol. 2, article 1, 2014. View at Google Scholar
  10. V. Kralj-Iglič, “Stability of membranous nanostructures: a possible key mechanism in cancer progression,” International Journal of Nanomedicine, vol. 7, pp. 3579–3596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Lokar, D. Kabaso, N. Resnik et al., “The role of cholesterol-sphingomyelin membrane nanodomains in the stability of intercellular membrane nanotubes,” International Journal of Nanomedicine, vol. 7, pp. 1891–1902, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Greenwalt, “The how and why of exocytic vesicles,” Transfusion, vol. 46, no. 1, pp. 143–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Mrówczyńska, U. Salzer, A. Iglič, and H. Hägerstrand, “Curvature factor and membrane solubilization, with particular reference to membrane rafts,” Cell Biology International, vol. 35, no. 10, pp. 991–995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Leroyer, F. Anfosso, R. Lacroix et al., “Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Camussi, M. C. Deregibus, S. Bruno, V. Cantaluppi, and L. Biancone, “Exosomes/microvesicles as a mechanism of cell-to-cell communication,” Kidney International, vol. 78, no. 9, pp. 838–848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Camussi, M. C. Deregibus, S. Bruno, C. Grange, V. Fonsato, and C. Tetta, “Exosome/microvesicle-mediated epigenetic reprogramming of cells,” American Journal of Cancer Research, vol. 1, no. 1, pp. 98–110, 2011. View at Google Scholar
  17. S. Robert, R. Lacroix, P. Poncelet et al., “High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles-brief report,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 4, pp. 1054–1058, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. P. Romancino, G. Paterniti, Y. Campos et al., “Identification and characterization of the nano-sized vesicles released by muscle cells,” FEBS Letters, vol. 587, no. 9, pp. 1379–1384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yuana, A. Sturk, and R. Nieuwland, “Extracellular vesicles in physiological and pathological conditions,” Blood Reviews, vol. 27, no. 1, pp. 31–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Diamant, R. Nieuwland, R. F. Pablo, A. Sturk, J. W. A. Smit, and J. K. Radder, “Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus,” Circulation, vol. 106, no. 19, pp. 2442–2447, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Janša, V. Šuštar, M. Frank et al., “Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases,” Blood Cells, Molecules, and Diseases, vol. 41, no. 1, pp. 124–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Suštar, A. Bedina-Zavec, R. Stukelj et al., “Post-prandial rise of microvesicles in peripheral blood of healthy human donors,” Lipids in health and disease, vol. 10, article 47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Štukelj, V. Suštar, A. Mrvar-Brečko et al., “Suppression of membrane vesiculation as anticoagulant and anti-metastatic mechanism. Role of stability of narrow necks,” General Physiology and Biophysics, vol. 32, no. 1, pp. 33–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Müller, A. Klocke, M. Alex et al., “Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets.,” The FASEB Journal, vol. 17, no. 3, pp. 476–478, 2003. View at Google Scholar · View at Scopus
  25. U. Rauch and S. Antoniak, “Tissue factor-positive microparticles in blood associated with coagulopathy in cancer,” Thrombosis and Haemostasis, vol. 97, no. 1, pp. 9–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Berckmans, R. Nieuwland, A. N. Böing, F. P. H. T. M. Romijn, C. E. Hack, and A. Sturk, “Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation,” Thrombosis and Haemostasis, vol. 85, no. 4, pp. 639–646, 2001. View at Google Scholar · View at Scopus
  27. M. Ikeda, S.-I. Iwamoto, H. Imamura, H. Furukawa, and T. Kawasaki, “Increased platelet aggregation and production of platelet-derived microparticles after surgery for upper gastrointestinal malignancy,” Journal of Surgical Research, vol. 115, no. 2, pp. 174–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Nomura, A. Imamura, M. Okuno et al., “Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines,” Thrombosis Research, vol. 98, no. 4, pp. 257–268, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Bohensky, R. deSteiger, C. Kondogiannis et al., “Adverse outcomes associated with elective knee arthroscopy: a population-based cohort study,” Arthroscopy, vol. 29, pp. 716–725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. T. Delis, N. Hunt, R. K. Strachan, and A. N. Nicolaides, “Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy,” Thrombosis and Haemostasis, vol. 86, no. 3, pp. 817–821, 2001. View at Google Scholar · View at Scopus
  31. M. P. Sheetz and S. J. Singer, “Biological membranes as bilayer couples. A molecular mechanism of drug erythrocyte interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 11, pp. 4457–4461, 1974. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Iglič, “A possible mechanism determining the stability of spiculated red blood cells,” Journal of Biomechanics, vol. 30, no. 1, pp. 35–40, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Hägerstrand, V. Kralj-Iglič, M. Fošnarič et al., “Endovesicle formation and membrane perturbation induced by polyoxyethyleneglycolalkylethers in human erythrocytes,” Biochimica et Biophysica Acta—Biomembranes, vol. 1665, no. 1-2, pp. 191–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Wróbel, M. Bobrowska-Hägerstrand, C. Lindqvist, and H. Hägerstrand, “Monitoring of membrane phospholipid scrambling in human erythrocytes and K562 cells with FM1-43-a comparison with annexin V-FITC,” Cellular and Molecular Biology Letters, vol. 19, no. 2, pp. 262–276, 2014. View at Publisher · View at Google Scholar
  35. A. Wróbel, “Effects of charged amphiphiles in depolarising solutions on potassium efflux and the osmotic fragility of human erythrocytes,” Bioelectrochemistry, vol. 73, no. 2, pp. 117–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Suwalsky, J. Belmar, F. Villena, M. J. Gallardo, M. Jemiola-Rzeminska, and K. Strzalka, “Acetylsalicylic acid (aspirin) and salicylic acid interaction with the human erythrocyte membrane bilayer induce in vitro changes in the morphology of erythrocytes,” Archives of Biochemistry and Biophysics, vol. 539, no. 1, pp. 9–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Šimundić, B. Drašler, V. Šuštar et al., “Effect of engineered TiO2 and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesicles,” BMC Veterinary Research, vol. 9, article 7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Bobrowska-Hägerstrand, V. Kralj-Iglič, A. Iglič, K. Bialkowska, B. Isomaa, and H. Hägerstrand, “Torocyte membrane endovesicles induced by octaethyleneglycol dodecylether in human erythrocytes,” Biophysical Journal, vol. 77, no. 6, pp. 3356–3362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Suštar, A. Bedina-Zavec, R. Stukelj et al., “Post-prandial rise of microvesicles in peripheral blood of healthy human donors,” Lipids in Health and Disease, vol. 10, article 47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. U. Seifert and R. Lipowsky, “Morphology of vesicles,” in Handbook of Biological Physics, R. Lipowsky and E. Sackmann, Eds., vol. 1, p. 421, 1995. View at Google Scholar
  41. G. H. W. Lim, M. Wortis, and R. Mukhopadhyay, “Stomatocyte-discocyte-echinocyte sequence of the human red blood cell: evidence for the bilayer-couple hypothesis from membrane mechanics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 26, pp. 16766–16769, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Iglič, V. Kralj-Iglič, and H. Hägerstrand, “Amphiphile induced echinocyte-spheroechinoeyte transformation of red blood cell shape,” European Biophysics Journal, vol. 27, no. 4, pp. 335–339, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Šuštar, A. Bedina-Zavec, R. Štukelj et al., “Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process,” International Journal of Nanomedicine, vol. 6, pp. 2737–2748, 2011. View at Google Scholar · View at Scopus
  44. E. Ogorevc, S. Hudoklin, P. Veranič, and V. Kralj-Iglič, “Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line,” Protoplasma, vol. 251, no. 3, pp. 699–702, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. S. E. Kjeldsen, A. B. Weder, B. Egan, R. Neubig, A. J. Zweifler, and S. Julius, “Effect of circulating epinephrine on platelet function and hematocrit,” Hypertension, vol. 25, no. 5, pp. 1096–1105, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Goto, S. Handa, E. Takahashi, S. Abe, M. Handa, and Y. Ikeda, “Synergistic effect of epinephrine and shearing on platelet activation,” Thrombosis Research, vol. 84, no. 5, pp. 351–359, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Hartung, “Toxicology for the twenty-first century,” Nature, vol. 460, no. 7252, pp. 208–212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. M. Schechtman, “Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods,” ILAR Journal, vol. 43, pp. S85–S94, 2002. View at Google Scholar · View at Scopus
  49. N. Hasiwa, M. Daneshian, P. Bruegger et al., “Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test,” ALTEX, vol. 30, pp. 169–208, 2013. View at Publisher · View at Google Scholar